Intrinsic Alpha

Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$3.73 +3.54%

+$0.17 today

Market cap
$1.98B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 7.24M

Average 7.31M

Returns on capital

Clover Health Investments, Corp. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-27.7%

avg 257890.5%

ROIC

-25.7%

avg 129827.6%

ROA

-15.8%

avg -45349.3%

Analysis

ROA is currently the strongest return metric at -15.8% versus its period average of -45349.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Jamie L. Reynoso

Chief Executive Officer of Medicare AdvantageUSD 1.47M572.77M0.53%

Andrew Toy

Co-Founder, Chief Executive Officer & DirectorUSD 1.32M479.08M1.75%

Conrad Wai

Chief Executive Officer of Counterpart HealthUSD 1.21M451.04M0.20%

Karen Soares

Chief Legal Officer, General Counsel, Senior VP & Corporate SecretaryUSD 513.2K481.57M0.30%

Kumar Dharmarajan

Chief Medical Officer of Clover Assistant—46——

Mark Spektor

Chief Medical Officer—55——

Aric Sharp

Chief Executive Officer of Value Based Care—53——

Vivek Garipalli

Co-Founder & Executive Chairman—470<0.01%

Wendy Richey

Chief Compliance Officer————

Joseph Frank Oldakowski

VP of Finance, Controller & Principal Accounting Officer—43462.30K0.09%

Clay Thornton

Interim Chief Financial Officer—36——

Rachel Fish

Chief People Officer————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 4, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

41

$8.71M

Net Transaction Value

−$8.71M

Net selling

Most Active

Reynoso Jamie L.

17 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 20, 26

Soares Karen

Direct

Sell$89.8K
Oct 19, 26

Reynoso Jamie L.

Direct

Sell$17.9K
Oct 15, 26

Toy Andrew

Direct

Sell$291K
Oct 15, 26

Soares Karen

Direct

Sell$68.7K
Oct 15, 26

THORNTON JOSEPH CLAY

Direct

Sell$21.5K
Oct 15, 26

Wai Conrad

Direct

Sell$110.6K
Oct 15, 26

Reynoso Jamie L.

Direct

Sell$85.5K
Oct 7, 26

Reynoso Jamie L.

Direct

Sell$9.3K
Oct 5, 26

Reynoso Jamie L.

Direct

Sell$38.7K
Oct 1, 26

Toy Andrew

Direct

Sell$1.3M

1–10 of 41

Summary

Insiders reported 0 buys worth $0.00 and 41 sells worth $8.71M over the last 12 months. That adds up to net selling of $8.71M. Reynoso Jamie L. was the most active insider with 17 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+20.6%
+21.7% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +20.6% over three years. Forward estimates point to Revenue at +21.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Clover Health Investments, Corp. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CLOV's management, answered from reported figures.

Who manages CLOV?

Clover Health Investments, Corp. (CLOV) lists 12 active executives. The top listed executive is Kumar Dharmarajan, Chief Medical Officer of Clover Assistant.

Are CLOV insiders buying or selling?

Recent insider activity shows net selling of $41.40M.